Wang Qianwen, Wang Xi, Yang Chun, Wang Long
Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, Wuhan, Hubei 430060, China.
Life Sci. 2021 Oct 15;283:119851. doi: 10.1016/j.lfs.2021.119851. Epub 2021 Jul 26.
Sleep disorders frequently comorbid with several cardiovascular diseases (CVDs), attracting increasing scientific attention and interest. Sleep disorders include insomnia, sleep-disordered breathing, restless legs syndrome, etc. It is well known that inflammation, sympathetic activation, and endothelial dysfunction play critical roles in sleep disorders, all of which are predisposing factors for CVDs. The comorbidity of sleep disorders and CVDs may have a bidirectional relationship. Patients with CVDs may have a high incidence of sleep disorders and vice versa. This review focused on the comorbidity of sleep disorders and CVDs and discussed the potential pathophysiological mechanisms and therapeutic strategies. In addition to the existing mechanisms, this review summarized novel potential mechanisms underlying comorbidities, such as gut microbiota, orexin, and extracellular vesicles, which may provide a theoretical basis for further basic research and clinical investigations on improving therapeutic outcomes.
睡眠障碍常与多种心血管疾病(CVDs)合并存在,正吸引着越来越多的科学关注和兴趣。睡眠障碍包括失眠、睡眠呼吸紊乱、不宁腿综合征等。众所周知,炎症、交感神经激活和内皮功能障碍在睡眠障碍中起关键作用,所有这些都是心血管疾病的易感因素。睡眠障碍与心血管疾病的合并存在可能具有双向关系。心血管疾病患者可能有较高的睡眠障碍发生率,反之亦然。本综述聚焦于睡眠障碍与心血管疾病的合并存在,并讨论了潜在的病理生理机制和治疗策略。除了现有的机制外,本综述还总结了合并存在的新潜在机制,如肠道微生物群、食欲素和细胞外囊泡,这可能为进一步改善治疗效果的基础研究和临床研究提供理论依据。